These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1296 related articles for article (PubMed ID: 22776244)

  • 1. Treatment options and recommendations to reduce preterm births in women with short cervix.
    Slager J; Lynne S
    J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of SuPPoRT: a multi-centre randomised controlled trial to compare three treatments: cervical cerclage, cervical pessary and vaginal progesterone, for the prevention of preterm birth in women who develop a short cervix.
    Hezelgrave NL; Watson HA; Ridout A; Diab F; Seed PT; Chin-Smith E; Tribe RM; Shennan AH
    BMC Pregnancy Childbirth; 2016 Nov; 16(1):358. PubMed ID: 27871275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical pessary versus vaginal progesterone in women with a singleton pregnancy, a short cervix, and no history of spontaneous preterm birth at less than 34 weeks' gestation: open label, multicentre, randomised, controlled trial.
    van Dijk CE; van Gils AL; van Zijl MD; Koullali B; van der Weide MC; van den Akker ES; Hermsen BJ; van Baal WM; Visser H; van Drongelen J; Vollebregt KC; Muller M; van der Made FW; Gordijn SJ; de Mooij YM; Oudijk MA; de Boer MA; Mol BW; Kazemier BM; Pajkrt E;
    BMJ; 2024 Mar; 384():e077033. PubMed ID: 38471724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
    Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH
    Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.
    Conde-Agudelo A; Romero R
    Am J Obstet Gynecol; 2016 Feb; 214(2):235-242. PubMed ID: 26450404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of follow-up cervical length screening in low-risk women with a cervical length of 26 to 29 mm.
    Boelig RC; Kripalu V; Chen SL; Cruz Y; Roman A; Berghella V
    Am J Obstet Gynecol; 2021 Aug; 225(2):179.e1-179.e6. PubMed ID: 33652056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Nicolaides KH
    Am J Obstet Gynecol; 2018 Feb; 218(2):161-180. PubMed ID: 29157866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMFM Consult Series #70: Management of short cervix in individuals without a history of spontaneous preterm birth.
    ; Biggio J;
    Am J Obstet Gynecol; 2024 Aug; 231(2):B2-B13. PubMed ID: 38754603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing cervical cerclage, pessary and vaginal progesterone for prevention of preterm birth in women with a short cervix (SuPPoRT): A multicentre randomised controlled trial.
    Hezelgrave NL; Suff N; Seed P; Robinson V; Carter J; Watson H; Ridout A; David AL; Pereira S; Hoveyda F; Girling J; Vinayakarao L; Tribe RM; Shennan AH;
    PLoS Med; 2024 Jul; 21(7):e1004427. PubMed ID: 39012912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial.
    Rehal A; Benkő Z; De Paco Matallana C; Syngelaki A; Janga D; Cicero S; Akolekar R; Singh M; Chaveeva P; Burgos J; Molina FS; Savvidou M; De La Calle M; Persico N; Quezada Rojas MS; Sau A; Greco E; O'Gorman N; Plasencia W; Pereira S; Jani JC; Valino N; Del Mar Gil M; Maclagan K; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2021 Jan; 224(1):86.e1-86.e19. PubMed ID: 32598909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.
    Hassan SS; Romero R; Vidyadhari D; Fusey S; Baxter JK; Khandelwal M; Vijayaraghavan J; Trivedi Y; Soma-Pillay P; Sambarey P; Dayal A; Potapov V; O'Brien J; Astakhov V; Yuzko O; Kinzler W; Dattel B; Sehdev H; Mazheika L; Manchulenko D; Gervasi MT; Sullivan L; Conde-Agudelo A; Phillips JA; Creasy GW;
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):18-31. PubMed ID: 21472815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of spontaneous preterm birth (excluding preterm premature rupture of membranes): Guidelines for clinical practice - Text of the Guidelines (short text)].
    Sentilhes L; Sénat MV; Ancel PY; Azria E; Benoist G; Blanc J; Brabant G; Bretelle F; Brun S; Doret M; Ducroux-Schouwey C; Evrard A; Kayem G; Maisonneuve E; Marcellin L; Marret S; Mottet N; Paysant S; Riethmuller D; Rozenberg P; Schmitz T; Torchin H; Langer B
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1446-1456. PubMed ID: 27836377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
    DeFranco EA; O'Brien JM; Adair CD; Lewis DF; Hall DR; Fusey S; Soma-Pillay P; Porter K; How H; Schakis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):697-705. PubMed ID: 17899571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update.
    Werner EF; Hamel MS; Orzechowski K; Berghella V; Thung SF
    Am J Obstet Gynecol; 2015 Oct; 213(4):554.e1-6. PubMed ID: 26071914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis.
    Conde-Agudelo A; Romero R; Nicolaides K; Chaiworapongsa T; O'Brien JM; Cetingoz E; da Fonseca E; Creasy G; Soma-Pillay P; Fusey S; Cam C; Alfirevic Z; Hassan SS
    Am J Obstet Gynecol; 2013 Jan; 208(1):42.e1-42.e18. PubMed ID: 23157855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cerclage for singleton pregnant patients on vaginal progesterone with progressive cervical shortening.
    Enakpene CA; DiGiovanni L; Jones TN; Marshalla M; Mastrogiannis D; Della Torre M
    Am J Obstet Gynecol; 2018 Oct; 219(4):397.e1-397.e10. PubMed ID: 30017683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix.
    Alfirevic Z; Owen J; Carreras Moratonas E; Sharp AN; Szychowski JM; Goya M
    Ultrasound Obstet Gynecol; 2013 Feb; 41(2):146-51. PubMed ID: 22991337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial.
    Cabrera-García L; Cruz-Melguizo S; Ruiz-Antorán B; Torres F; Velasco A; Martínez-Payo C; Avendaño-Solá C;
    Trials; 2015 Sep; 16():427. PubMed ID: 26407852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM; Lewis DF
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.